Non-Expressed Donor KIR3DL1 Alleles May Represent a Risk Factor for Relapse after T-Replete Haploidentical Hematopoietic Stem Cell Transplantation
Nolwenn Legrand(Centre National de la Recherche Scientifique), Katia Gagne(Inserm), Maxime Jullien(Centre National de la Recherche Scientifique), Patrice Chevallier(Hotel Dieu Hospital), Peter Parham(Stanford University), Catherine Willem(Centre National de la Recherche Scientifique), Marie‐Claire Devilder(Centre National de la Recherche Scientifique), Ketevan Gendzekhadze(City Of Hope National Medical Center), Perla Salameh(Centre National de la Recherche Scientifique), E Ferron(Centre National de la Recherche Scientifique), Gaëlle David(Centre National de la Recherche Scientifique), Christelle Retière(Centre National de la Recherche Scientifique)
Cited by 2
Related Papers
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2016|347
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL
|Blood|2016|329